Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norovirus VP1 is the major structural protein of human norovirus, a non-enveloped icosahedral virus approximately 27 nm in diameter that causes acute gastroenteritis. The protein comprises 180 copies arranged as 90 dimers with T=3 icosahedral symmetry, organized into shell (S) and protruding (P) domains that establish the capsid architecture. The P2 subdomain, located at the virion surface, contains the binding pocket for histo-blood group antigens (HBGAs), which serve as cellular attachment factors essential for infection.[3][5] Recent structural analyses reveal that VP1 exhibits significant conformational flexibility, particularly in the P domain, which enables both receptor binding and immune evasion through antibody escape mechanisms.[3] While VP1 itself is not a traditional therapeutic target for direct inhibition, it represents an important focus for vaccine development and the identification of vulnerable epitopes that could be exploited for therapeutic interventions targeting norovirus infection.
Not applicable (structural protein, not a therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norovirus major capsid protein VP1 (Viral Protein 1) (VP1).